Triple combination of hepatic arterial infusion chemotherapy, immune checkpoint inhibitors, and tyrosine kinase inhibitors for treatment of advanced hepatocellular carcinoma: more robust evidence is still needed
@article{CCO129757, author = {Mohammad Saeid Rezaee-Zavareh and Ju Dong Yang}, title = {Triple combination of hepatic arterial infusion chemotherapy, immune checkpoint inhibitors, and tyrosine kinase inhibitors for treatment of advanced hepatocellular carcinoma: more robust evidence is still needed}, journal = {Chinese Clinical Oncology}, volume = {13}, number = {5}, year = {2024}, keywords = {}, abstract = {}, issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/129757} }